Subscribe to RSS
DOI: 10.1055/s-0038-1648908
Homozygous Type I Protein C Deficiency in Two Unrelated Families Exhibiting Thrombophilia Related to Ala136→Pro or Arg286→His Mutations
Publication History
Received 28 March 1994
Accepted after revision 23 June 1994
Publication Date:
06 July 2018 (online)
Summary
Separate single nucleotide mutations have been identified in two unrelated homozygous type I protein C deficient individuals suffering from thrombophilia. Each mutation, initially established by direct DNA sequencing of polymerase chain reaction amplification products, results in an amino acid substitution. The first mutation (PCClamart) results in an Ala136 to Pro substitution in the protein’s second epidermal growth factor-like domain. The second mutation (PCMtinchen) results in an Arg286 to His substitution in the serine protease domain. Comparison of the location of these two mutations and the relative conservation of the two regions in homologous vitamin K-dependent plasma proteins is consistent with the difference in severity of protein C deficiency and disease in the two individuals. Both mutations result in the abolition of a naturally occurring restriction endonuclease site, thereby allowing independent confirmation of the mutations and rapid and unambiguous genetic analysis of protein C deficiency in family members. In both families, the genetic analysis has proven useful in cases where an assignment of the protein C status based upon clinical laboratory measurements was either ambiguous or incorrect.
-
References
- 1 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
- 2 Clouse LH, Comp PC. The regulation of hemostasis: The protein C system. N Engl J Med 1986; 314: 1298-1304
- 3 Seegers W, McCoy LE, Groben HD, Sakuragawa N, Agrawal BBL. Purification and properties of autoprothrombin II a: An anticoagulant perhaps also related to fibrinolysis. Thromb Res 1972; 1: 43
- 4 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
- 5 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
- 6 Marlar RA. Protein C in thromboembolic disease. Semin Thromb Hemost 1985; 11: 387-393
- 7 Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost 1982; 48: 1-5
- 8 Pabinger-Fasching I, Bertina RM, Lechner K, Niessner H, Kominger CH. Protein C deficiency in two Austrian families. Thromb Haemost 1983; 50: 810-813
- 9 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 1983; 309: 340-344
- 10 Horellou MH, Conard J, Bertina RM, Samama M. Congenital protein C deficiency and thrombotic disease in nine French families. Brit Med J 1984; 289: 1285-1287
- 11 Seligson U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
- 12 Marlar RA, Montgomery RR, Madden RM. Homozygous protein C deficiency. In: Protein C and Related Proteins Bertina RM. ed. Churchill Livingstone Press; New York NY: 1988: 160-181
- 13 Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-995
- 14 Pabinger I, Lechner K. Acquired protein C and protein S deficiency. In: Protein C and Related Proteins Bertina RM. ed. Churchill Livingstone Press; New York NY: 1988: 213-225
- 15 Pabinger I, Allaart CF, Hermans J, Briët E, Bertina RM. the Protein C Transmitter Study Group. Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the Diagnostic Procedure Report on a study of the SSC subcommittee on protein C and protein S. Thromb Haemost 1992; 68: 470-474
- 16 Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchernia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-1568
- 17 Schwarz HP, Linnau Y, Schramm W, Dreyfus M, Bauer KA. Treatment of protein C deficiency with a monoclonal antibody purified protein C concentrate. Circulation 1990; 82: 111-134 (Abstr.)
- 18 Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL. A 5.3 Kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 1991; 77: 551-559
- 19 Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL. Protein CVermont: Symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 1992; 79: 1456-1465
- 20 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 1986; 83: 546-550
- 21 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-4677
- 22 Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985; 13: 5233-5247
- 23 Nicham S, Guichaoua JS, Contant G, Martinoli JL. Dosage rapide de l’activité de la protéine C. Ann Biol Clin (Paris) 1988; 46: 805-809
- 24 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefson DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172
- 25 Long GL. Structure and evolution of the human genes encoding protein C and coagulation factors VII, IX, and X. Cold Spr Harbor Symp Quant Biol 1986; 51: 525-529
- 26 Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci USA 1982; 79: 6461-6464
- 27 Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci USA 1984; 81: 3699-3702
- 28 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-2416
- 29 Degen SJ, MacGillivray RTA, Davie EW. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry 1983; 22: 2087-2097
- 30 Stenflo J. Structure-function relationships of EGF modules in vitamin K-dependent clotting factors. Blood 1991; 78: 1637-1651
- 31 Giannelli F, Green PM, High KA, Sommer S, Lillicrap DP, Ludwig M, Olek K, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG. Haemophilia B: Database of point mutations and short additions and deletions - third edition, 1992. Nucleic Acids Res 1992; (Suppl. 20) 2027-2063
- 32 Seibel P, Degoul F, Romero N, Marsac C, Kadenbach B. Identification of point mutations by mispairing PCR as exemplified in MERRF disease. Bio-chem Biophys Res Commun 1990; 173: 561-565